Table 3.

Relative expression of adipose metabolism associated genes in the epididymal fat pad, liver and colon of rats (treatment versus control)

Genes	Epididymal fat pad		Liver		Colon
	Control	Treatment	Control	Treatment	Control	Treatment
PPARγ	1.02 ± 0.26	7.74 ± 1.64**	1.01 ± 0.17	5.49 ± 1.33**	1.01 ± 0.17	2.53 ± 0.51**
Fiaf	1.02 ± 0.23	0.56 ± 0.02*	1.03 ± 0.27	0.39 ± 0.07*	1.06 ± 0.42	0.90 ± 0.06
LPL	1.00 ± 0.08	4.15 ± 0.57**	1.04 ± 0.20	4.75 ± 0.30**	1.01 ± 0.18	2.91 ± 0.71*
PP2A	1.03 ± 0.03	2.37 ± 0.52*	1.01 ± 0.13	2.46 ± 0.18**	1.02 ± 0.24	2.51 ± 0.23*
SREBP-1c	1.01 ± 0.06	6.56 ± 0.41**	1.00 ± 0.10	3.76 ± 0.57**	1.01 ± 0.15	2.28 ± 0.28*
ChREBP	1.03 ± 0.05	3.27 ± 0.21**	1.01 ± 0.09	4.01 ± 0.50**	1.02 ± 0.18	4.71 ± 0.65**
FASN	1.01 ± 0.09	3.29 ± 0.50**	1.01 ± 0.13	3.77 ± 0.26**	1.02 ± 0.19	7.73 ± 1.19**
Leptin	1.01 ± 0.07	0.92 ± 0.28	1.08 ± 0.45	0.48 ± 0.18	1.03 ± 0.27	1.21 ± 0.11
Adiponectin	1.02 ± 0.13	9.35 ± 1.79**	–	–	–	–

^*P < 0.05 (compared with the control, confidence interval is 95%)

^**P < 0.01 (compared with the control, confidence interval is 95%).

Fiaf, fasting-induced adipose factor; LPL, lipoprotein lipase; PP2A, protein phosphatase 2A; –, no expression detected